148 related articles for article (PubMed ID: 21281853)
1. Pharmacotherapy for obese adolescents.
Greydanus DE; Bricker LA; Feucht C
Pediatr Clin North Am; 2011 Feb; 58(1):139-53, xi. PubMed ID: 21281853
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacological treatment of obesity: past, present and future].
Simonyi G; Pados G; Medvegy M; Bedros JR
Orv Hetil; 2012 Mar; 153(10):363-73. PubMed ID: 22370224
[TBL] [Abstract][Full Text] [Related]
4. Past, Present, and Future of Pharmacologic Therapy in Obesity.
RodrÃguez JE; Campbell KM
Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200
[TBL] [Abstract][Full Text] [Related]
5. Rimonabant for the treatment of overweight and obese people.
Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for obesity in menopausal women.
Samat A; Rahim A; Barnett A
Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
[TBL] [Abstract][Full Text] [Related]
7. Emerging concepts in the medical and surgical treatment of obesity.
Aylwin S; Al-Zaman Y
Front Horm Res; 2008; 36():229-259. PubMed ID: 18230906
[TBL] [Abstract][Full Text] [Related]
8. Experimental drugs take aim at obesity.
Vastag B
JAMA; 2003 Apr; 289(14):1763-4. PubMed ID: 12684341
[No Abstract] [Full Text] [Related]
9. Drug treatment of the overweight patient.
Bray GA; Ryan DH
Gastroenterology; 2007 May; 132(6):2239-52. PubMed ID: 17498515
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic options for overweight adolescents.
Dunican KC; Desilets AR; Montalbano JK
Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
[TBL] [Abstract][Full Text] [Related]
11. [The endocannabinoid system and treatment of obesity].
Aronsen L
Tidsskr Nor Laegeforen; 2008 Feb; 128(5):570-1. PubMed ID: 18311201
[TBL] [Abstract][Full Text] [Related]
12. CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.
Scheen AJ
J Neuroendocrinol; 2008 May; 20 Suppl 1():139-46. PubMed ID: 18426513
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of obesity in pediatric patients.
Boland CL; Harris JB; Harris KB
Ann Pharmacother; 2015 Feb; 49(2):220-32. PubMed ID: 25366340
[TBL] [Abstract][Full Text] [Related]
14. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
15. Drug treatment of obesity.
Bray GA; Ryan DH
Psychiatr Clin North Am; 2011 Dec; 34(4):871-80. PubMed ID: 22098810
[TBL] [Abstract][Full Text] [Related]
16. Safety of obesity drugs.
Greenway FL; Caruso MK
Expert Opin Drug Saf; 2005 Nov; 4(6):1083-95. PubMed ID: 16255666
[TBL] [Abstract][Full Text] [Related]
17. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
Padwal RS; Majumdar SR
Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
[TBL] [Abstract][Full Text] [Related]
18. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
19. Obesity medications and the treatment of type 2 diabetes.
Greenway F
Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
[TBL] [Abstract][Full Text] [Related]
20. [Association of obesity and depression].
Rihmer Z; Purebl G; Faludi G; Halmy L
Neuropsychopharmacol Hung; 2008 Oct; 10(4):183-9. PubMed ID: 19213197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
